• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国非酒精性脂肪性肝病患者中未诊断糖尿病和糖负荷后高血糖的患病率

Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.

作者信息

Wong V W S, Hui A Y, Tsang S W C, Chan J L Y, Wong G L H, Chan A W H, So W Y, Cheng A Y S, Tong P C Y, Chan F K L, Sung J J Y, Chan H L Y

机构信息

Institute of Digestive Diseases, The Chinese University of Hong Kong, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong SAR.

出版信息

Aliment Pharmacol Ther. 2006 Oct 15;24(8):1215-22. doi: 10.1111/j.1365-2036.2006.03112.x.

DOI:10.1111/j.1365-2036.2006.03112.x
PMID:17014580
Abstract

BACKGROUND

Non-alcoholic fatty liver disease is prevalent in affluent countries and is strongly associated with metabolic syndrome.

AIM

To study the prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.

METHODS

73 consecutive patients with biopsy-proven non-alcoholic fatty liver disease and no history of diabetes underwent comprehensive metabolic screening. Diagnosis of diabetes and impaired glucose regulation was based on the 2006 American Diabetes Association criteria.

RESULTS

The prevalence of undiagnosed diabetes and impaired glucose tolerance in non-alcoholic fatty liver disease patients was 33% and 29%, respectively. Among patients with 2-h plasma glucose above 7.8 mm, 47% had normal fasting glucose (below 5.6 mm). Impaired glucose tolerance was more common in patients with non-alcoholic steatohepatitis than those with simple hepatic steatosis (P = 0.036), and 2-h plasma glucose correlated with fibrosis stage (Spearman coefficient: 0.25, P = 0.046). In a binary logistic regression analysis, high fasting glucose and low high-density lipoprotein cholesterol were independent factors associated with diabetes. Nevertheless, if oral glucose tolerance test was only performed in non-alcoholic fatty liver disease patients with impaired fasting glucose, 20.8% of diabetes cases would be missed.

CONCLUSIONS

Isolated postchallenge hyperglycaemia is common among Chinese non-alcoholic fatty liver disease patients without history of diabetes. It is associated with histological severe disease, and cannot be accurately predicted by any fasting glucose cut-off.

摘要

背景

非酒精性脂肪性肝病在富裕国家普遍存在,且与代谢综合征密切相关。

目的

研究中国非酒精性脂肪性肝病患者中未诊断糖尿病及餐后高血糖的患病率。

方法

对73例经活检证实为非酒精性脂肪性肝病且无糖尿病病史的患者进行全面代谢筛查。糖尿病和糖调节受损的诊断依据2006年美国糖尿病协会标准。

结果

非酒精性脂肪性肝病患者中未诊断糖尿病和糖耐量受损的患病率分别为33%和29%。在2小时血浆葡萄糖高于7.8 mmol/L的患者中,47%的患者空腹血糖正常(低于5.6 mmol/L)。非酒精性脂肪性肝炎患者糖耐量受损比单纯性肝脂肪变性患者更常见(P = 0.036),且2小时血浆葡萄糖与纤维化分期相关(Spearman系数:0.25,P = 0.046)。在二元逻辑回归分析中,空腹血糖高和高密度脂蛋白胆固醇低是与糖尿病相关的独立因素。然而,如果仅对空腹血糖受损的非酒精性脂肪性肝病患者进行口服葡萄糖耐量试验,将漏诊20.8%的糖尿病病例。

结论

在中国无糖尿病病史的非酒精性脂肪性肝病患者中,孤立性餐后高血糖很常见。它与组织学上的严重疾病相关,且不能通过任何空腹血糖切点准确预测。

相似文献

1
Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.中国非酒精性脂肪性肝病患者中未诊断糖尿病和糖负荷后高血糖的患病率
Aliment Pharmacol Ther. 2006 Oct 15;24(8):1215-22. doi: 10.1111/j.1365-2036.2006.03112.x.
2
Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese.
Aliment Pharmacol Ther. 2004 Jul 1;20(1):45-9. doi: 10.1111/j.1365-2036.2004.02012.x.
3
Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.葡萄糖耐量异常是非酒精性脂肪性肝病患者脂肪性肝炎和肝纤维化的一个预测指标。
Scand J Gastroenterol. 2005 Dec;40(12):1469-77. doi: 10.1080/00365520500264953.
4
Silent non-alcoholic fatty liver disease-a clinical-histological study.无症状非酒精性脂肪性肝病——一项临床组织学研究
J Hepatol. 2004 Nov;41(5):751-7. doi: 10.1016/j.jhep.2004.07.010.
5
Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis.亚洲非酒精性脂肪性肝炎患者纤维化的预测因素
J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):116-21. doi: 10.1111/j.1440-1746.2005.04146.x.
6
Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults.日本成年人非酒精性脂肪性肝病的患病率及其与糖代谢受损的关系。
Diabet Med. 2005 Sep;22(9):1141-5. doi: 10.1111/j.1464-5491.2005.01582.x.
7
Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.不同血清丙氨酸氨基转移酶水平的非酒精性脂肪性肝病患者的代谢和组织学特征。
Aliment Pharmacol Ther. 2009 Feb 15;29(4):387-96. doi: 10.1111/j.1365-2036.2008.03896.x. Epub 2008 Nov 17.
8
Non-alcoholic steatohepatitis in type 2 diabetes mellitus.2型糖尿病中的非酒精性脂肪性肝炎
J Gastroenterol Hepatol. 2004 Aug;19(8):854-8. doi: 10.1111/j.1440-1746.2004.03312.x.
9
Significant correlations between severe fatty liver and risk factors for metabolic syndrome.重度脂肪肝与代谢综合征风险因素之间存在显著相关性。
J Gastroenterol Hepatol. 2007 Dec;22(12):2118-23. doi: 10.1111/j.1440-1746.2006.04698.x.
10
[Non-alcoholic fatty liver disease--new view].[非酒精性脂肪性肝病——新视角]
Pol Merkur Lekarski. 2008 Jun;24(144):568-71.

引用本文的文献

1
Investigation of cardiovascular risk factors in diabetic and nondiabetic patients with nonalcoholic fatty liver disease.糖尿病和非糖尿病非酒精性脂肪性肝病患者心血管危险因素的调查。
J Res Med Sci. 2024 Aug 2;29:51. doi: 10.4103/jrms.jrms_830_23. eCollection 2024.
2
Liver fibrosis according to diabetes status and relation to cardiovascular risk and mortality in US adults.美国成年人中根据糖尿病状况划分的肝纤维化及其与心血管风险和死亡率的关系
Am Heart J Plus. 2024 Sep 6;46:100457. doi: 10.1016/j.ahjo.2024.100457. eCollection 2024 Oct.
3
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.
非酒精性脂肪性肝病或代谢相关脂肪性肝病患者 2 型糖尿病的全球流行病学:系统评价和荟萃分析。
BMC Med. 2024 Mar 6;22(1):101. doi: 10.1186/s12916-024-03315-0.
4
Changes in the Epidemiology of Hepatocellular Carcinoma in Asia.亚洲肝细胞癌流行病学的变化
Cancers (Basel). 2022 Sep 15;14(18):4473. doi: 10.3390/cancers14184473.
5
Risk of liver fibrosis in patients with prediabetes and diabetes mellitus.糖尿病前期和糖尿病患者发生肝纤维化的风险。
PLoS One. 2022 Jun 2;17(6):e0269070. doi: 10.1371/journal.pone.0269070. eCollection 2022.
6
Correlation of Adiponectin Gene Polymorphisms and With Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.脂联素基因多态性与非酒精性脂肪性肝病风险的相关性:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2022 Mar 23;13:798417. doi: 10.3389/fendo.2022.798417. eCollection 2022.
7
Fatty liver index and progression to type 2 diabetes: a 5-year longitudinal study in Spanish workers with pre-diabetes.脂肪肝指数与 2 型糖尿病进展:西班牙糖尿病前期工人的 5 年纵向研究。
BMJ Open. 2021 Aug 25;11(8):e045498. doi: 10.1136/bmjopen-2020-045498.
8
The metabolic profiles and body composition of lean metabolic associated fatty liver disease.瘦型代谢相关脂肪性肝病的代谢特征和身体成分。
Hepatol Int. 2021 Apr;15(2):405-412. doi: 10.1007/s12072-021-10147-0. Epub 2021 Feb 4.
9
High incidence of hepatocellular carcinoma and cirrhotic complications in patients with psychiatric illness: a territory-wide cohort study.精神疾病患者肝细胞癌和肝硬化并发症的高发率:全港范围的队列研究。
BMC Gastroenterol. 2020 Apr 29;20(1):128. doi: 10.1186/s12876-020-01277-0.
10
Bredemolic Acid Ameliorates Selected Liver Function Biomarkers in a Diet-Induced Prediabetic Rat Model.布瑞得美酸可改善饮食诱导的糖尿病前期大鼠模型中的部分肝功能生物标志物。
Can J Gastroenterol Hepatol. 2020 Feb 20;2020:2475301. doi: 10.1155/2020/2475301. eCollection 2020.